The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinsons disease

Louise Collins

doi:10.1016/j.nsa.2022.100244

The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinsons disease

Louise Collins

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Neuroscience Applied
DOIs	https://doi.org/10.1016/j.nsa.2022.100244
Publication status	Published - 2022

Keywords

In vitro
Parkinsons disease
Class (philosophy)
Pharmacology
Disease
Degeneration (medical)
Chemistry
Medicine
Biochemistry
Internal medicine
Pathology
Computer science
Artificial intelligence

Access to Document

10.1016/j.nsa.2022.100244

https://openalex.org/W4313201510Licence: CC BY-NC-ND

Cite this

@article{a05fd40c129040e2841678b3e321245e,

title = "The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinsons disease",

keywords = "In vitro, Parkinsons disease, Class (philosophy), Pharmacology, Disease, Degeneration (medical), Chemistry, Medicine, Biochemistry, Internal medicine, Pathology, Computer science, Artificial intelligence",

author = "Louise Collins",

year = "2022",

doi = "10.1016/j.nsa.2022.100244",

language = "English",

journal = "Neuroscience Applied",

issn = "2772-4085",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinsons disease

AU - Collins, Louise

PY - 2022

Y1 - 2022

KW - In vitro

KW - Parkinsons disease

KW - Class (philosophy)

KW - Pharmacology

KW - Disease

KW - Degeneration (medical)

KW - Chemistry

KW - Medicine

KW - Biochemistry

KW - Internal medicine

KW - Pathology

KW - Computer science

KW - Artificial intelligence

U2 - 10.1016/j.nsa.2022.100244

DO - 10.1016/j.nsa.2022.100244

M3 - Article

SN - 2772-4085

JO - Neuroscience Applied

JF - Neuroscience Applied

ER -